Opinion|Videos|September 6, 2024
Optimizing Pneumococcal Vaccination Efforts in High-Risk Patients
The key opinion leaders explore effective methods for educating patients about pneumococcal vaccination, highlighting its importance and benefits, while also addressing the impact of COVID-19 on vaccine hesitancy and potential fatigue in the general population.
Advertisement
Episodes in this series
- What How can we engage with patients to educate and emphasize the need and benefits associated with immunizing against pneumococcal disease?
- The COVID-19 pandemic has created a significant amount of vaccine fatigue and hesitancy. How do you identify these in your practice and how can they be overcome to achieve optimal vaccination rates?
- What impact do social determinants such as racial and ethnic disparities have on the vaccination rates of pneumococcal vaccines in underserved populations (health equity vs. equality)?
- What are the cost barriers that are present with pneumococcal vaccination and how can they be overcome?
- What does good collaboration look like between stakeholders in an effort to vaccinate in underserved populations?
Advertisement
Related to this article
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
3
Glucose Monitoring: Timing Makes Every Reading Count
4
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
5